Lesson 1High-intensity statin initiation: timing, expected benefits, monitoring for adverse effectsExplains when and how to start high-intensity statins in suspected ACS, expected plaque stabilisation benefits, baseline labs, monitoring for muscle or liver harm, and counselling for long-term sticking to it.
Timing of statin start in ACS pathwayChoosing appropriate statin and doseBaseline liver and muscle assessmentsMonitoring for myopathy and hepatotoxicityPatient counseling and adherence supportLesson 2Oxygen therapy: evidence-based thresholds for use, titration to target SpO2, risks of hyperoxiaExamines oxygen therapy in suspected ACS, stressing evidence-based start limits, adjusting to target oxygen saturation, avoiding excess oxygen, and noting reasons and patient response.
When to start oxygen in suspected ACSTarget SpO2 ranges and titration stepsRisks and mechanisms of hyperoxia harmDevice selection and flow adjustmentsMonitoring and documenting oxygen responseLesson 3Nitroglycerin: sublingual administration steps, hemodynamic checks, contraindications (PDE-5 inhibitors), management of hypotensionOutlines safe nitroglycerin use, including under-tongue steps, before and after dose blood flow checks, no-go factors like PDE-5 inhibitors, and handling low blood pressure from nitro.
Sublingual nitroglycerin administration stepsPre-dose blood pressure and pain checksScreening for PDE-5 inhibitor useRecognizing nitroglycerin side effectsManaging and documenting hypotensionLesson 4Aspirin: dosing, mechanism in ACS, contraindications, assessment before and after administrationGives focused review of aspirin in ACS, including loading and upkeep doses, blood clot prevention action, no-go factors, and structured checks before and after for safety and effect.
Aspirin loading and maintenance dosingMechanism of platelet inhibition in ACSContraindications and relative cautionsPre-dose assessment and risk screeningPost-dose monitoring and reassessmentLesson 5Medication interaction and allergy checks: cross-checking home meds, diabetes and beta-blocker interactions, renal dosing considerationsFocuses on systematically spotting allergies, past bad reactions, and high-risk drug clashes, including diabetes treatments, beta-blockers, and kidney-cleared drugs, to avoid harm in ACS patients.
Structured allergy and reaction historyCross-checking home and inpatient medsDiabetes drugs and beta-blocker maskingRenal dosing and nephrotoxic combinationsUsing EHR alerts and pharmacist supportLesson 6Overview of ACS pharmacotherapy: antiplatelets, anticoagulants, nitrates, beta-blockers, statins, oxygen rationaleReviews core ACS medicines, their actions, indications, and no-go factors, stressing initial choice, order, and bedside safety checks to balance blood flow relief with bleeding and blood pressure risks.
Roles of antiplatelet agents in ACSAnticoagulant options and selectionUse of nitrates for ischemic chest painEarly beta-blocker therapy considerationsHigh-intensity statins in ACS careOxygen use and current ACS evidenceLesson 7Anticoagulation with enoxaparin: dosing based on weight/renal function, timing relative to procedures, bleeding risk assessment and monitoringCovers enoxaparin for ACS blood thinning, including weight and kidney-based dosing, timing around procedures, bleeding risk check, monitoring plans, and coordinating with heart team.
Weight-based dosing calculationsRenal impairment dose adjustmentsTiming with PCI and other proceduresBaseline and ongoing bleeding assessmentMonitoring anti-Xa and lab parametersReversal and management of major bleedingLesson 8Beta-blockers (metoprolol): indications, IV vs PO use, blood pressure and heart rate criteria, dose titration and monitoring for bradycardiaReviews metoprolol in ACS, including reasons, IV versus oral choice, blood pressure and heart rate limits, dose adjustment, and monitoring for slow heart rate, low pressure, and breathing issues.
Indications and contraindications in ACSIV versus oral metoprolol selectionBlood pressure and heart rate thresholdsDose titration and reassessmentMonitoring for bradycardia and hypotensionLesson 9Documentation and communication with the provider about medication responses and lab-guided adjustmentsDetails best ways to record medicine reasons, responses, and side effects, and share with doctors to guide lab-based dose changes and treatment step-up or step-down.
Recording indications and time of dosingCharting responses and side effectsCommunicating critical changes promptlyUsing labs to guide dose adjustmentsHandoff reports and interdisciplinary notesLesson 10Monitoring for adverse effects: hypotension, bradycardia, bleeding, allergic reactions, and stepwise response algorithmsCovers early spotting and handling of low pressure, slow heart rate, bleeding, and allergy reactions after ACS medicines, using step-by-step plans, escalation points, and noting responses.
Vital sign and perfusion surveillanceBleeding risk signs and bedside checksRecognition of drug-induced bradycardiaIdentifying and treating allergic reactionsStepwise response and escalation pathwaysPost-event reassessment and documentation
